Atlas FDA

TactiFlex™ Ablation Catheter, Sensor Enabled™ (TactiFlex SE)

FDA premarket approval P220013/S010 · decided 2023-10-24

Approval details

PMA number
P220013
Supplement
S010
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
TactiFlex™ Ablation Catheter, Sensor Enabled™ (TactiFlex SE)
Generic name
Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
Applicant
ABBOTT MEDICAL
Date received
2023-09-29
Decision date
2023-10-24
Days to decision
25 days
Decision code
OK30
Product code
OAE
Advisory committee
Cardiovascular
Expedited review
No
Location
Plymouth, MN
Statement
a change to the manufacturing process to consolidate the number of adhesives used in the manufacture of the TactiFlex Ablation Catheter, Sensor Enabled

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18